CSE/RAMM (CSE/RAMM)

Canadian Securities Exchange: CSE/RAMM · CAD

CA$0.01

+0.01 (+100.0%)· Recorded snapshot

Market cap	596.9K
Revenue (ttm)	1.3M
Net income (ttm)	-9.1M
EPS (ttm)	-CA$0.08
Shares out	119.4M
Volume	200,000
Beta	0.39

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.3M
Net income (ttm): -9.1M
EPS (ttm): -CA$0.08
Market cap: 596.9K

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 11P50 16.8P75 23.9

Trailing P/En/a

P25 9.9P50 23.3P75 38.5

ROE-112.4

P25 -104.1P50 -30P75 6.7

ROIC-32.5

P25 -55.9P50 -12.1P75 5

Benchmarks · 1M

All CSE/RAMM indicators

Market & fundamental data

Available fields

160

Groups with data

Currency

CAD

Showing 160 of 160 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2027-03-01
Enterprise value	CAD 619,366
Exchange	Canadian Securities Exchange
Financial currency	CAD
Financial report date	2026-07-31
First seen	2026-05-10
Fiscal year end	October
Founded	1987
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CA75150G1046
Last earnings date	2026-02-27
Last refreshed	2026-10-29
Market cap	CAD 596,947
Next earnings date	2027-03-01
Price	CAD 0.01
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-29
Symbol	cse/RAMM
Website	https://www.wearerammpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-760.52%
EV/Sales	0.49x
FCF / EV yield	-203.7%
FCF yield	-211.35%
Industry forward P/E	34.4x
P/B ratio	0.16x
P/S ratio	0.47x
Price / tangible book value	0.16x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	59.14%
Operating margin	-335.1%
Pretax margin	-714.73%
ROA	-24.54%
ROA (5Y)	-15.1%
ROCE	-113.53%
ROE	-112.44%
ROE (5Y)	-50.7%
ROIC	-32.51%
Tax / revenue	0.84%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
Gross profit growth	-16.35%
Gross profit growth (Q)	2,985.03%
Gross profit growth 3Y	-14.13%
Gross profit growth 5Y	14.38%
Net income growth years	1
Revenue growth	-66.4%
Revenue growth (Q)	-70.56%
Revenue growth (QoQ)	36.49%
Revenue growth 3Y	-37.14%
Revenue growth 5Y	-21.64%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	CAD 287,648
EBIT	CAD -4.3M
EBITDA	CAD -4M
EPS	CAD -0.08
FCF per share	CAD -0.01
Financing cash flow	CAD -72,529
Free cash flow	CAD -1.3M
Gross profit	CAD 750,369
Income taxes	CAD 10,699
Investing cash flow	CAD 957,552
Net borrowing	CAD -69,793
Net cash flow	CAD -382,282
Net income	CAD -9.1M
Operating income	CAD -4.3M
Revenue	CAD 1.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-17.57
Book value per share	CAD 0.03
Debt / equity	0.05
Interest coverage	-17.82
Long-term assets	CAD 5.9M
Long-term liabilities	CAD 0
Net cash (debt)	CAD -22,423
Net cash / market cap	-3.76%
Net debt / equity	0.01
Piotroski F-Score	2
Property, plant and equipment	CAD 5.9M
Shareholders' equity	CAD 3.7M
Tangible book value	CAD 3.7M
Tangible book value per share	CAD 0.03
Total assets	CAD 6.7M
Total cash	CAD 147,129
Total debt	CAD 169,552
Total liabilities	CAD 3M
WACC	29.59%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.12
Current assets	CAD 829,007
Current liabilities	CAD 3M
Current ratio	0.28
Inventory turnover	0.54
Net working capital	CAD -2.1M
Quick ratio	0.16
Working capital	CAD -2.1M
Working capital turnover	-2.78

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.02
1D price change	100%
1W price change	100%
1W total return	100%
1Y price change	-50%
1Y return CAGR	-50.02%
1Y total return	-50%
20-day SMA	CAD 0.01
200-day SMA	CAD 0.03
3Y price change	-80%
3Y return CAGR	-41.51%
3Y total return	-80%
50-day SMA	CAD 0.01
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.25
52-week high date	2025-11-10
52-week low	CAD 0.01
52-week low date	2026-10-26
5Y price change	-97.5%
5Y return CAGR	-52.19%
5Y total return	-97.5%
6M price change	-33.33%
6M total return	-33.33%
All-time high	CAD 1.19
All-time high date	2021-03-15
All-time low	CAD 0.01
All-time low date	2024-12-16
Average true range (ATR)	CAD 0.00
Average volume	81K
Beta (1Y)	-7.33
Beta (2Y)	-3.41
Beta (5Y)	0.39
Change from 52-week high	-96%
Change from 52-week low	100%
Change from all-time high	-99.16%
Change from all-time low	100%
Change from open	0%
Day's gap	100%
Dollar volume	CAD 2,000
High price	CAD 0.01
Low price	CAD 0.01
Monthly RSI	41.22
Open price	CAD 0.01
Previous close	CAD 0.01
Price vs 150-day SMA	-53.05%
Price vs 20-day SMA	33.33%
Price vs 200-day SMA	-62.69%
Price vs 50-day SMA	-32.89%
Relative volume	2.47
RSI	50.23
Sharpe ratio	1.35
Sharpe ratio (3Y)	0.75
Sortino ratio	4.33
Sortino ratio (3Y)	2.1
Volume	200K
Weekly RSI	43.63
YTD price change	-83.33%
YTD total return	-83.33%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	81.9M
Shares change (QoQ)	0%
Shares held by insiders	31.43%
Shares outstanding	119.4M

Deeper analysis on CSE/RAMM

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/RAMM report

Is a complete CSE/RAMM research report available?

No complete published report is available for cse/RAMM (CSE/RAMM) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/RAMM (CSE/RAMM)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/RAMM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/RAMM indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Performance and technicals

Ownership and float

Deeper analysis on CSE/RAMM

Frequently asked questions